NCT00004176View on ClinicalTrials.gov

Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

October 31, 1998

Primary Completion Date

February 28, 2001

Study Completion Date

February 28, 2001

Conditions
Drug/Agent Toxicity by Tissue/OrganLung CancerRadiation Toxicity
Interventions
DRUG

amifostine trihydrate

DRUG

cisplatin

DRUG

etoposide

RADIATION

radiation therapy

Trial Locations (4)

15213

University of Pittsburgh Cancer Institute, Pittsburgh

63110

Washington University Barnard Cancer Center, St Louis

80218

Rocky Mountain Cancer Center, Denver

27599-7295

Lineberger Comprehensive Cancer Center, UNC, Chapel Hill

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Washington University School of Medicine

OTHER

NCT00004176 - Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter